AM

Anil Miradwal

Active Director Director DIN 01929177
DIN 01929177 First appointment Oct 2007 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Oct 2007
Shareholding value •••• Premium profile

About Anil Miradwal

Data last updated:

Anil Miradwal is a Director at Vishwanath Hospital And Research Centre Private Limited (since 2007), Director at Kanchann Devbuild Private Limited (since 2020) and Director at Kanchann Build Arc Private Limited (since 2020). The companies operate in Healthcare, Real Estate and Construction and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹1.3 Lakh; the largest is Vishwanath Hospital And Research Centre Private Limited at ₹64,900 (FY 2025). Earlier, Anil Miradwal was a Director at Manokesh Industries Private Limited (2023–2025) and Director at Asthvinayak Enterprises India Private Limited (2018–2022).

DIN 01929177
Primary Designation Director
Industry Healthcare
First Appointment 01 Oct 2007
Oldest Company Age 29 yrs
Largest company Vishwanath Hospital And Research Centre Private Limited · ₹64,900 (FY 2025)
Combined revenue ₹1.3 Lakh across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Oct 20071997₹64,900 (FY 2025)Active
Kanchann Devbuild Private Limited U70101MP2012PTC029504
Director01 Jul 20202012₹40,900 (FY 2024)Active
Kanchann Build Arc Private Limited U70101MP2013PTC030478
Director01 Jul 20202013₹29,100 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Manokesh Industries Private Limited U46499MP2006PTC019073
Director23 Jan 20232006₹3.4 Lakh (FY 2025)Active
Director07 Sep 20182018₹89.36 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kanchann Devbuild Private Limited
Kanchann Build Arc Private Limited
Vishwanath Hospital And Research Centre Private Limited
Manokesh Industries Private Limited
Premium access

Shareholding and investment profile for Anil Miradwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Miradwal

Anil Miradwal currently holds 3 directorships: Vishwanath Hospital And Research Centre Private Limited (Director, since 01 Oct 2007, revenue ₹64,900 (FY 2025)); Kanchann Devbuild Private Limited (Director, since 01 Jul 2020, revenue ₹40,900 (FY 2024)); Kanchann Build Arc Private Limited (Director, since 01 Jul 2020, revenue ₹29,100 (FY 2024)).

Anil Miradwal was first appointed on 01 Oct 2007 as Director at Vishwanath Hospital And Research Centre Private Limited. The most recent appointment on record is 23 Jan 2023 at Manokesh Industries Private Limited.

The 3 current companies of Anil Miradwal that report revenue have a combined latest revenue of ₹1.3 Lakh: Vishwanath Hospital And Research Centre Private Limited ₹64,900 (FY 2025); Kanchann Devbuild Private Limited ₹40,900 (FY 2024); Kanchann Build Arc Private Limited ₹29,100 (FY 2024).

Anil Miradwal held 2 earlier board appointments: Manokesh Industries Private Limited (Director, 23 Jan 2023 to 07 Dec 2025); Asthvinayak Enterprises India Private Limited (Director, 07 Sep 2018 to 17 Aug 2022).

The current boards of Anil Miradwal's companies include Kailash Saini (Vishwanath Hospital And Research Centre Private Limited), Manoj Saini (Kanchann Devbuild Private Limited), Kundan Singh Chawda (Kanchann Build Arc Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available